The CYP2C19*17 variant is not associated with an increased response to clopidogrel, but it increases the risk for the development of carotid artery stenosis.

Rakicević, Ljiljana; Novković, Mirjana; Backović, Dragana; Strugarević, Evgenija; Kovac, Mirjana; Kusic-Tisma,  Jelena; Radojkovic, Dragica

Rezultati

eNauka > Rezultati > The CYP2C19*17 variant is not associated with an increased response to clopidogrel, but it increases the risk for the development of carotid artery stenosis.

Naziv:	The CYP2C19*17 variant is not associated with an increased response to clopidogrel, but it increases the risk for the development of carotid artery stenosis.
Autori:	Rakicević, Ljiljana ; Novković, Mirjana ; Backović, Dragana; Strugarević, Evgenija; Kovac, Mirjana; Kusic-Tisma, Jelena ; Radojkovic, Dragica
Godina:	2021
Publikacija:	7th European Section and 8th North American Section Meeting of the International Academy of Cardiovascular Sciences (IACS) - Cardioprotection and Cardiometabolic Diseases: From Bench to Bedside, Banja Luka, 20-23 September 2021
Tip rezultata:	Konferencijski rad
URI:	https://enauka.gov.rs/handle/123456789/905659
URL:	http://www.iacs.sav.sk/IACS2021.pdf
Izvor metapodataka:	(Preuzeto iz ORCID-a) Rakićević, Ljiljana
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.